Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/111068
Title: Prenatal antidepressant exposure associated with CYP2E1 DNA methylation change in neonates
Author: Gurnot, Cécile
Martín-Subero, José Ignacio
Mah, Sarah M.
Weikum, Whitney
Goodman, Sarah J.
Brain, Ursula
Werker, Janet F.
Kobor, Michael S.
Esteller, Manel
Oberlander, Tim F.
Hensch, Takao K.
Keywords: Antidepressius
Depressió psíquica
Embaràs
Infants nadons
ADN
Metilació
Neurotransmissors
Serotonina
Antidepressants
Mental depression
Pregnancy
Newborn infants
DNA
Methylation
Neurotransmitters
Serotonin
Issue Date: Jun-2015
Publisher: Landes Bioscience
Abstract: Some but not all neonates are affected by prenatal exposure to serotonin reuptake inhibitor antidepressants (SRI) and maternal mood disturbances. Distinguishing the impact of these 2 exposures is challenging and raises critical questions about whether pharmacological, genetic, or epigenetic factors can explain the spectrum of reported outcomes. Using unbiased DNA methylation array measurements followed by a detailed candidate gene approach, we examined whether prenatal SRI exposure was associated with neonatal DNA methylation changes and whether such changes were associated with differences in birth outcomes. Prenatal SRI exposure was first associated with increased DNA methylation status primarily at CYP2E1(βNon-exposed = 0.06, βSRI-exposed = 0.30, FDR = 0); however, this finding could not be distinguished from the potential impact of prenatal maternal depressed mood. Then, using pyrosequencing of CYP2E1 regulatory regions in an expanded cohort, higher DNA methylation status both the mean across 16 CpG sites (P < 0.01) and at each specific CpG site (P < 0.05) was associated with exposure to lower 3rd trimester maternal depressed mood symptoms only in the SRI-exposed neonates, indicating a maternal mood x SRI exposure interaction. In addition, higher DNA methylation levels at CpG2 (P = 0.04), CpG9 (P = 0.04) and CpG10 (P = 0.02), in the interrogated CYP2E1 region, were associated with increased birth weight independently of prenatal maternal mood, SRI drug exposure, or gestational age at birth. Prenatal SRI antidepressant exposure and maternal depressed mood were associated with altered neonatal CYP2E1 DNA methylation status, which, in turn, appeared to be associated with birth weight.
Note: Versió postprint del document publicat a: https://doi.org/10.1080/15592294.2015.1026031
It is part of: Epigenetics, 2015, vol. 10, num. 5, p. 361-372
Related resource: https://doi.org/10.1080/15592294.2015.1026031
URI: http://hdl.handle.net/2445/111068
ISSN: 1559-2294
Appears in Collections:Articles publicats en revistes (Ciències Fisiològiques)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Articles publicats en revistes (Fonaments Clínics)

Files in This Item:
File Description SizeFormat 
659383.pdf576.74 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.